A risk score to predict need for treatment for upper-gastrointestinal haemorrhage.

TL;DR: This guideline presents recommendations for the step-wise management of patients with overt upper gastrointestinal bleeding, and patients with established cardiovascular disease who require aspirin should start PPI and generally re-institute aspirin soon after bleeding ceases.

TL;DR: AIMS65 is a simple, accurate risk score that predicts in-hospital mortality, LOS, and cost in patients with acute upper GI bleeding and is validated by using data routinely available at initial evaluation.

TL;DR: Copeptin showed promising diagnostic and prognostic role in the management of sepsis, together with its possible role in monitoring the response to treatment, and no significant differences were found in copeptin temporal profile among different subgroups.

TL;DR: The Glasgow-Blatchford bleeding score identifies many patients presenting to general hospitals with upper-gastrointestinal haemorrhage who can be managed safely as outpatients, allowing more appropriate use of in-patient resources.

TL;DR: It is hypothesized that, due to complete lack of isoleucine in hemoglobin, ingestion of blood into the gut presents the organism with protein of low biological value, leading to decreased protein synthesis and to net protein degradation, which in turn may result in increased ammonia‐ and ureagenesis.

TL;DR: These results confirm previous findings in animals and healthy volunteers that plasma isoleucine decreases after simulated upper gastrointestinal haemorrhage, and supports the hypothesis that the absence of isoleUCine in blood protein causes decreased plasma isolucine values after gastrointestinal haemsorrhages.

TL;DR: Azotemia which persists beyond this time indicates either continuation of bleeding, continuation of hypovolemia insult or intrinsic renal disease, an indication for re-evaluation of fluid management.